StocksFundsScreenerSectorsWatchlists
IQV

IQV - IQVIA Holdings Inc Stock Price, Fair Value and News

234.23USD-3.79 (-1.59%)Market Closed

Market Summary

IQV
USD234.23-3.79
Market Closed
-1.59%

IQV Stock Price

View Fullscreen

IQV RSI Chart

IQV Valuation

Market Cap

42.5B

Price/Earnings (Trailing)

31.29

Price/Sales (Trailing)

2.84

EV/EBITDA

16.61

Price/Free Cashflow

19.77

IQV Price/Sales (Trailing)

IQV Profitability

EBT Margin

9.74%

Return on Equity

22.22%

Return on Assets

5.09%

Free Cashflow Yield

5.06%

IQV Fundamentals

IQV Revenue

Revenue (TTM)

15.0B

Rev. Growth (Yr)

3.45%

Rev. Growth (Qtr)

3.53%

IQV Earnings

Earnings (TTM)

1.4B

Earnings Growth (Yr)

106.61%

Earnings Growth (Qtr)

54.79%

Breaking Down IQV Revenue

Last 7 days

-3.0%

Last 30 days

-8.4%

Last 90 days

9.5%

Trailing 12 Months

15.5%

How does IQV drawdown profile look like?

IQV Financial Health

Current Ratio

0.86

Debt/Equity

2.12

Debt/Cashflow

0.17

IQV Investor Care

Buy Backs (1Y)

2.27%

Diluted EPS (TTM)

7.29

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202314.5B14.7B14.9B15.0B
202214.0B14.1B14.3B14.4B
202112.0B12.9B13.5B13.9B
202011.2B10.9B11.0B11.4B
201910.5B10.7B10.9B11.1B
20189.9B10.1B10.2B10.4B
20177.7B8.5B9.5B9.7B
20165.9B6.0B6.1B6.8B
20155.5B5.6B5.6B5.7B
20145.2B5.2B5.4B5.5B
20134.9B5.0B5.0B5.1B
20124.5B4.6B4.7B4.9B
20110004.3B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of IQVIA Holdings Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 01, 2024
bousbib ari
sold
-7,936,190
250
-31,678
see remarks
Mar 01, 2024
bousbib ari
acquired
2,791,910
65.16
42,847
see remarks
Mar 01, 2024
bousbib ari
back to issuer
-2,791,920
249
-11,169
see remarks
Feb 29, 2024
staub w richard
sold
-3,494,030
247
-14,100
see remarks
Feb 28, 2024
knightly kevin c
sold
-2,153,180
250
-8,607
see remarks
Feb 28, 2024
knightly kevin c
acquired
1,154,210
87.4005
13,206
see remarks
Feb 28, 2024
knightly kevin c
back to issuer
-1,154,440
251
-4,599
see remarks
Feb 16, 2024
knightly kevin c
back to issuer
-950,333
241
-3,941
see remarks
Feb 16, 2024
knightly kevin c
sold
-3,247,170
241
-13,468
see remarks
Feb 16, 2024
sherbet eric
sold
-241,500
241
-1,000
see remarks

1–10 of 50

Which funds bought or sold IQV recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 11, 2024
CONGRESS ASSET MANAGEMENT CO /MA
reduced
-26.17
-57,185
238,981
-%
Apr 11, 2024
Fortitude Family Office, LLC
unchanged
-
39,858
468,605
0.32%
Apr 11, 2024
Roble, Belko & Company, Inc
unchanged
-
-
5,000
-%
Apr 11, 2024
Gulf International Bank (UK) Ltd
added
0.4
449,000
5,064,000
0.13%
Apr 11, 2024
Running Oak Capital LLC
added
11.95
1,990,380
10,892,700
1.75%
Apr 11, 2024
Bangor Savings Bank
unchanged
-
861
10,116
-%
Apr 11, 2024
SALEM INVESTMENT COUNSELORS INC
reduced
-52.45
-143,018
154,769
-%
Apr 11, 2024
Ballentine Partners, LLC
added
11.77
65,337
360,115
0.01%
Apr 11, 2024
CENTRAL BANK & TRUST CO
reduced
-44.05
-15,100
23,770
-%
Apr 11, 2024
First Affirmative Financial Network
reduced
-4.25
12,379
279,340
0.21%

1–10 of 50

Are Funds Buying or Selling IQV?

Are funds buying IQV calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own IQV
No. of Funds

Unveiling IQVIA Holdings Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
harris associates l p
5.34%
9,747,869
SC 13G
Feb 13, 2024
vanguard group inc
11.55%
21,077,827
SC 13G/A
Jan 25, 2024
blackrock inc.
8.3%
15,166,087
SC 13G/A
Feb 09, 2023
vanguard group inc
11.55%
21,447,600
SC 13G/A
Feb 07, 2023
blackrock inc.
8.5%
15,763,249
SC 13G/A
Feb 07, 2022
blackrock inc.
7.9%
15,139,662
SC 13G/A
Feb 10, 2021
vanguard group inc
10.93%
20,954,687
SC 13G/A
Jan 29, 2021
blackrock inc.
7.7%
14,826,277
SC 13G/A
Feb 10, 2020
vanguard group inc
10.03%
19,475,899
SC 13G/A
Feb 10, 2020
vanguard group inc
9.97%
19,346,266
SC 13G/A

Recent SEC filings of IQVIA Holdings Inc

View All Filings
Date Filed Form Type Document
Mar 04, 2024
4
Insider Trading
Mar 04, 2024
4
Insider Trading
Mar 01, 2024
144
Notice of Insider Sale Intent
Mar 01, 2024
4
Insider Trading
Feb 29, 2024
144
Notice of Insider Sale Intent
Feb 28, 2024
144
Notice of Insider Sale Intent
Feb 23, 2024
DEFA14A
DEFA14A
Feb 23, 2024
DEF 14A
DEF 14A
Feb 23, 2024
ARS
ARS
Feb 21, 2024
4
Insider Trading

Peers (Alternatives to IQVIA Holdings Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
177.5B
23.9B
-6.01% -5.66%
37.43
7.43
-10.33% -33.23%
41.4B
3.7B
-7.85% 3.70%
48.95
11.3
8.72% 24.44%
41.2B
6.7B
-4.79% -0.38%
33.37
6.12
-2.81% -6.58%
14.2B
9.3B
-0.68% -9.91%
16.66
1.54
-6.38% -9.73%
13.0B
2.5B
16.81% 6.46%
-63.45
5.18
19.93% 67.26%
12.4B
4.1B
-7.63% 17.34%
26.1
3
3.86% -2.39%
12.2B
1.9B
-3.01% 103.01%
43.03
6.45
29.17% 15.26%
11.4B
1.1B
6.13% 81.38%
-26.22
10.53
31.99% 20.63%
MID-CAP
2.7B
929.2M
-20.76% -25.66%
1.7K
2.88
28.93% 111.61%
2.2B
563.9M
-3.74% -26.28%
-4.64
3.95
25.45% 26.76%
SMALL-CAP
441.7M
280.3M
-19.18% -10.04%
-2.32
1.58
-12.89% -148.37%
85.8M
31.2M
-2.40% -86.64%
-0.97
2.75
5.03% -1.81%
42.6M
9.2M
-5.99% -38.94%
-2.55
4.65
11.85% 44.12%
6.5M
9.0M
-20.83% -63.11%
-0.89
0.72
-53.31% 2.21%
183.8K
25.9M
-50.00% -94.83%
-0.01
0.01
-57.78% -93.11%

IQVIA Holdings Inc News

Latest updates
Defense World47 minutes ago
Yahoo Finance12 Apr 202412:00 pm
Simply Wall St11 Apr 202411:16 am
Yahoo Finance11 Mar 202407:00 am

IQVIA Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue3.5%3,8683,7363,7283,6523,7393,5623,5413,5683,6363,3913,4383,4093,2982,7862,5212,7542,8952,7692,7402,6842,688
  S&GA Expenses10.8%556502482513583517483488542498482442491460431407484395436419443
EBITDA Margin2.6%0.22*0.21*0.21*0.20*0.20*0.20*0.20*0.20*0.20*0.20*0.19*0.19*0.18*--------
Interest Expenses0%18118116914112810894.0086.0090.0092.0094.0099.00102100108106109114114110106
Income Taxes-300.0%-10251.0081.0071.0048.0070.0071.0071.0059.0012.0048.0044.0063.00-3.00-5.0017.0068.00-1.008.0041.0030.00
Earnings Before Taxes6.9%373349375362275360328400376273222257194102-25.0010296.0069.0078.00109104
EBT Margin6.3%0.10*0.09*0.09*0.09*0.09*0.10*0.10*0.09*0.08*0.07*0.06*0.04*0.03*--------
Net Income54.8%469303297289227283256325316261175217119101-21.0091.0016.0057.0060.0058.0069.00
Net Income Margin20.6%0.09*0.08*0.07*0.07*0.08*0.08*0.08*0.08*0.07*0.06*0.05*0.03*0.03*--------
Free Cashflow28.1%747583402417560863329508692844539867750--------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets2.7%26,68125,97726,03625,73925,33724,22324,41324,96924,68924,03323,93724,46724,56423,83723,18323,07823,25122,89223,06823,10922,549
  Current Assets7.5%5,5965,2085,3295,3284,9814,7524,9114,7724,7634,5345,0685,5795,0904,6454,2084,2774,1263,9953,9783,9993,874
    Cash Equivalents12.4%1,3761,2241,3821,4941,2161,2741,4281,3871,3661,4701,8072,3051,8141,4641,109927837863938936891
  Net PPE5.0%523498510520532507529531497485470472482452444445458451458437434
  Goodwill2.0%14,56714,28814,17814,01513,92113,17713,10413,53213,30113,12412,55112,41512,65412,36312,13311,98912,15911,91911,93711,85711,800
Liabilities2.0%20,56920,17220,28819,80719,57218,87619,06119,05018,64718,20418,17718,23018,28417,73017,33117,27616,98816,49816,28716,24415,595
  Current Liabilities-1.5%6,4916,5896,5436,6575,5785,2535,1045,1575,2414,8474,8194,8684,5584,1393,8433,9073,9453,5763,4953,5023,534
  Long Term Debt5.1%12,95512,32212,43311,83312,59512,24312,61512,54712,03412,08112,14012,09212,38412,19511,96511,89411,54511,44411,29911,18710,907
    LT Debt, Current-45.1%7181,3091,3441,34315215115290.0091.0091.0014714414914414213910098.00100100100
    LT Debt, Non Current5.1%12,95512,32212,43311,83312,59512,24312,61512,54712,03412,08112,14012,09212,38412,19511,96511,89411,54511,44411,29911,18710,907
Shareholder's Equity5.3%6,1125,8055,7485,9325,7655,3475,3525,9196,0425,8295,7606,2376,2806,1075,8525,8026,2636,3946,7816,8656,954
  Retained Earnings11.1%4,6924,2233,9203,6233,3343,1072,8242,5682,2431,9251,6641,4891,2771,1581,0571,080998982925865807
Shares Outstanding-0.5%182183183186186187189190191192192192191--------
Minority Interest------------284279261261260260263258250240
Float---40,800---40,200---45,700---26,300---28,600--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations28.1%747583402417560863329508692844539867750574472163583330391113417
  Share Based Compensation-4.3%45.0047.0050.0075.0058.0061.0045.0030.0042.0048.0048.0032.0026.0033.0036.00-59.0027.0034.0026.0035.00
Cashflow From Investing63.0%-212-573-596-222-477-717-199-613-647-1,095-185-176-236-191-219-150-280-400-195-315-178
Cashflow From Financing-191.7%-420-14495.0087.00-193-251-29.00144-138-66.00-863-168-198-53.00-73.00107-34339.00-200228-158
  Buy Backs59.0%22914449012965.0021049040320495.0045.0062.00101-1.00345270298236145604

IQV Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Revenues$ 14,984$ 14,410$ 13,874
Cost of revenues, exclusive of depreciation and amortization9,7459,3829,233
Selling, general and administrative expenses2,0532,0711,964
Depreciation and amortization1,1251,1301,264
Restructuring costs842820
Income from operations1,9771,7991,393
Interest income(36)(13)(6)
Interest expense672416375
Loss on extinguishment of debt6026
Other (income) expense, net(124)33(130)
Income before income taxes and equity in (losses) earnings of unconsolidated affiliates1,4591,3631,128
Income tax expense101260163
Income before equity in (losses) earnings of unconsolidated affiliates1,3581,103965
Equity in (losses) earnings of unconsolidated affiliates0(12)6
Net income1,3581,091971
Net income attributable to non-controlling interests00(5)
Net income attributable to IQVIA Holdings Inc.$ 1,358$ 1,091$ 966
Earnings per share attributable to common stockholders:   
Basic (in dollars per share)$ 7.39$ 5.82$ 5.05
Diluted (in dollars per share)$ 7.29$ 5.72$ 4.95
Weighted average common shares outstanding:   
Basic (in shares)183.8187.6191.4
Diluted (in shares)186.3190.6195.0

IQV Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
ASSETS  
Cash and cash equivalents$ 1,376$ 1,216
Trade accounts receivable and unbilled services, net3,3812,917
Prepaid expenses141151
Income taxes receivable3243
Investments in debt, equity and other securities12093
Other current assets and receivables546561
Total current assets5,5964,981
Property and equipment, net523532
Operating lease right-of-use assets296331
Investments in debt, equity and other securities10568
Investments in unconsolidated affiliates13494
Goodwill14,56713,921
Other identifiable intangibles, net4,8394,820
Deferred income taxes166118
Deposits and other assets, net455472
Total assets26,68125,337
Current liabilities:  
Accounts payable and accrued expenses3,5643,316
Unearned income1,7991,797
Income taxes payable116161
Current portion of long-term debt718152
Other current liabilities294152
Total current liabilities6,4915,578
Long-term debt, less current portion12,95512,595
Deferred income taxes202464
Operating lease liabilities223264
Other liabilities698671
Total liabilities20,56919,572
Commitments and contingencies (Note 1 and 12)
Stockholders’ equity:  
Common stock and additional paid-in capital, 400.0 shares authorized as of December 31, 2023 and 2022, $0.01 par value, 257.2 shares issued and 181.5 shares outstanding as of December 31, 2023; 256.4 shares issued and 185.7 shares outstanding as of December 31, 202211,02810,898
Retained earnings4,6923,334
Treasury stock, at cost, 75.7 and 70.7 shares as of December 31, 2023 and 2022, respectively(8,741)(7,740)
Accumulated other comprehensive loss(867)(727)
Total stockholders’ equity6,1125,765
Total liabilities and stockholders’ equity$ 26,681$ 25,337
IQV
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.
 CEO
 WEBSITEiqvia.com
 INDUSTRYDiagnostics & Research
 EMPLOYEES65535

IQVIA Holdings Inc Frequently Asked Questions


What is the ticker symbol for IQVIA Holdings Inc? What does IQV stand for in stocks?

IQV is the stock ticker symbol of IQVIA Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of IQVIA Holdings Inc (IQV)?

As of Fri Apr 12 2024, market cap of IQVIA Holdings Inc is 42.49 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of IQV stock?

You can check IQV's fair value in chart for subscribers.

What is the fair value of IQV stock?

You can check IQV's fair value in chart for subscribers. The fair value of IQVIA Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of IQVIA Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for IQV so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is IQVIA Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether IQV is over valued or under valued. Whether IQVIA Holdings Inc is cheap or expensive depends on the assumptions which impact IQVIA Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IQV.

What is IQVIA Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, IQV's PE ratio (Price to Earnings) is 31.29 and Price to Sales (PS) ratio is 2.84. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IQV PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on IQVIA Holdings Inc's stock?

In the past 10 years, IQVIA Holdings Inc has provided 0.165 (multiply by 100 for percentage) rate of return.